Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Formula I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108137587B details a novel electrochemical recycling process for Finerenone intermediates, offering significant cost reduction and scalability for API manufacturing.
Novel patent CN119528902A offers high-yield KRAS G12D intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN112250639B details a novel Ru/Cu-catalyzed route for heterocyclic arylamines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN109963835B reveals a streamlined 2-step convergent synthesis for MMAF analogs, offering significant cost reduction in ADC manufacturing and enhanced supply chain reliability.
Patent CN112390816B discloses a scalable synthesis of oxazepine derivatives for Hepatitis B treatment, offering improved yield and safety for API manufacturing.
Patent CN107325122B reveals a streamlined synthesis for prostaglandin intermediates, offering significant cost reduction and enhanced safety for pharmaceutical manufacturing.
Patent CN107531680B reveals a novel route for toxin intermediates, offering high optical purity and yield for cost reduction in ADC toxin manufacturing.
Patent CN102127014B reveals a high-yield Pd-catalyzed route for azaphenanthrone intermediates, offering simplified processing and superior scalability for pharmaceutical manufacturing.
Novel copper-catalyzed route for allene thioethers offers mild conditions and high yields, ensuring reliable supply chain for complex API synthesis.
Novel radical cyclization method for 2-CF3 cyclopentenones. Efficient, mild conditions, scalable for API intermediates and fine chemicals.
Patent CN111718372B discloses a novel axial chiral ligand enabling high-yield asymmetric allylic substitution with excellent enantioselectivity for cost-effective API manufacturing.
Novel metal-free catalytic route for 1,3-dihydroisobenzofuran derivatives offering high yields and mild conditions for pharma intermediates.
Novel two-step synthesis of axial chiral ligands from aryl halides offers cost-effective, high-enantioselectivity solutions for pharmaceutical manufacturing.